| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Champions Oncology, Inc. (CSBR) has 6 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. CSBR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 299.2K | $1.80M | - | |
| 10% | 25.5K | $153.3K | - | |
| Dir | 21.2K | $127.7K | - | |
| Dir | 21.2K | $127.7K | - | |
| Dir | 13.8K | $83.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2020 | Morris Ronnie | CEO | Buy | 75 | $4.75 | $356.25 | - | |
| Mar 6, 2020 | New Enterprise Associates 14, L.P. | 10% Owner | Sell | 708,155 | $6.99 | $4,950,003.45 | -29.2% | |
| Dec 19, 2018 | Morris Ronnie | CEO | Buy | 20,000 | $7.44 | $148,800.00 | +2.5% | |
| Nov 6, 2018 | Mendelson Daniel Newman55 | Director | Sell | 5,000 | $13.75 | $68,750.00 | -8.0% | |
| Oct 1, 2018 | Ackerman Joel58 | Director | Sell | 22,535 | $17.02 | $383,545.70 | -2.2% | |
| Sep 20, 2018 | Mendelson Daniel Newman55 | Director | Sell | 8,333 | $13.02 | $108,495.66 | -11.8% | |
| Mar 27, 2018 | Morris Ronnie | CEO | Buy | 4,535 | $3.59 | $16,298.05 | +0.2% | |
| Mar 23, 2018 | Morris Ronnie | CEO | Buy | 700 | $3.50 | $2,446.50 | - | |
| Oct 21, 2016 | Morris Ronnie | President | Buy | 30,000 | $1.66 | $49,900.00 | +0.9% | |
| Oct 19, 2016 | Morris Ronnie | President | Buy | 10,000 | $1.70 | $17,000.00 | +0.9% |